Research
And Grants
To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.
Cincinnati Children's Hospital – $50,000
$50,000.00
May 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
SIOPe DIPG/DMG Registry
$779,018.00
March 2022
Renewal of the European DIPG/DMG Registry
Massachusetts General Hospital – $50,000
$50,000.00
November 2021
Targeted Protein Degradation for DIPG Therapy
CONNECT2007 - $385,794
$385,794.00
September 2021
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE
CONNECT2109A - $705,764
$705,764.00
September 2021
CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)
CONNECT Consortium - $278,619
$278,619.00
September 2021
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors
Institute of Cancer Research – $113,747
$113,747.00
September 2021
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG
Institute of Cancer Research – $498,716
$498,716.00
September 2021
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical